# OPENLANE, Inc.: financial statements, quarterly

OPLN · NYSE · CIK 1395942 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/opln.md) · [Financials](/companies/opln/financials.md) · [Filings](/companies/opln/filings.md) · [Insiders](/companies/opln/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/opln/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [428](/filings/0001395942-25-000007.md) | [406](/filings/0001395942-25-000007.md) | [430](/filings/0001395942-26-000006.md) | [444](/filings/0001395942-26-000006.md) | [460](/filings/0001395942-26-000006.md) | [455](/filings/0001395942-26-000006.md) | [460](/filings/0001395942-26-000019.md) | [482](/filings/0001395942-26-000031.md) | [498](/filings/0001395942-26-000006.md) | [494](/filings/0001395942-26-000006.md) | [528](/filings/0001395942-26-000019.md) | [555](/filings/0001395942-26-000031.md) |
| Selling, general and administrative | $m | [105](/filings/0001395942-25-000007.md) | [101](/filings/0001395942-25-000007.md) | [107](/filings/0001395942-26-000006.md) | [105](/filings/0001395942-26-000006.md) | [97.7](/filings/0001395942-26-000006.md) | [99.7](/filings/0001395942-26-000006.md) | [107](/filings/0001395942-26-000019.md) | [114](/filings/0001395942-26-000031.md) | [111](/filings/0001395942-26-000006.md) | [113](/filings/0001395942-26-000006.md) | [124](/filings/0001395942-26-000019.md) | [124](/filings/0001395942-26-000031.md) |
| Operating income | $m | [32.3](/filings/0001395942-25-000007.md) | [23.4](/filings/0001395942-25-000007.md) | [36.8](/filings/0001395942-26-000006.md) | [23.9](/filings/0001395942-26-000006.md) | [42.5](/filings/0001395942-26-000006.md) | [79.0](/filings/0001395942-26-000006.md) | [51.7](/filings/0001395942-26-000019.md) | [47.4](/filings/0001395942-26-000031.md) | [55.0](/filings/0001395942-26-000006.md) | [42.5](/filings/0001395942-26-000006.md) | [73.8](/filings/0001395942-26-000019.md) | [67.5](/filings/0001395942-26-000031.md) |
| Interest expense | $m | [5.2](/filings/0001395942-25-000007.md) | [5.3](/filings/0001395942-25-000007.md) | [7.1](/filings/0001395942-26-000006.md) | [5.5](/filings/0001395942-26-000006.md) | [4.6](/filings/0001395942-26-000006.md) | [4.6](/filings/0001395942-26-000006.md) | [4.0](/filings/0001395942-26-000019.md) | [3.1](/filings/0001395942-26-000031.md) | [1.1](/filings/0001395942-26-000006.md) | [9.9](/filings/0001395942-26-000006.md) | [10.1](/filings/0001395942-26-000019.md) | [10.0](/filings/0001395942-26-000031.md) |
| Income tax | $m | [12.7](/filings/0001395942-25-000007.md) | [7.6](/filings/0001395942-25-000007.md) | [10.7](/filings/0001395942-26-000006.md) | [7.5](/filings/0001395942-26-000006.md) | [13.1](/filings/0001395942-26-000006.md) | [16.7](/filings/0001395942-26-000006.md) | [15.8](/filings/0001395942-26-000019.md) | [18.3](/filings/0001395942-26-000031.md) | [8.2](/filings/0001395942-26-000006.md) | [(27.8)](/filings/0001395942-26-000006.md) | [16.4](/filings/0001395942-26-000019.md) | [16.8](/filings/0001395942-26-000031.md) |
| Net income | $m | [12.7](/filings/0001395942-24-000073.md) | [14.3 d](/filings/0001395942-26-000006.md) | [18.5](/filings/0001395942-25-000027.md) | [10.7](/filings/0001395942-25-000051.md) | [28.4](/filings/0001395942-25-000068.md) | [52.3 d](/filings/0001395942-26-000006.md) | [36.9](/filings/0001395942-26-000019.md) | [33.4](/filings/0001395942-26-000031.md) | [47.9](/filings/0001395942-25-000068.md) | [59.5 d](/filings/0001395942-26-000006.md) | [48.9](/filings/0001395942-26-000019.md) | [44.3](/filings/0001395942-26-000031.md) |
| Diluted EPS | $ per share | [0.01](/filings/0001395942-24-000073.md) | not reported | [0.05](/filings/0001395942-25-000027.md) | [0.00](/filings/0001395942-25-000051.md) | [0.12](/filings/0001395942-25-000068.md) | not reported | [0.18](/filings/0001395942-26-000019.md) | [0.15](/filings/0001395942-26-000031.md) | [0.25](/filings/0001395942-25-000068.md) | not reported | [0.35](/filings/0001395942-26-000019.md) | [0.32](/filings/0001395942-26-000031.md) |
| Basic EPS | $ per share | [0.01](/filings/0001395942-24-000073.md) | not reported | [0.05](/filings/0001395942-25-000027.md) | [0.00](/filings/0001395942-25-000051.md) | [0.12](/filings/0001395942-25-000068.md) | not reported | [0.18](/filings/0001395942-26-000019.md) | [0.16](/filings/0001395942-26-000031.md) | [0.26](/filings/0001395942-25-000068.md) | not reported | [0.35](/filings/0001395942-26-000019.md) | [0.33](/filings/0001395942-26-000031.md) |

- Revenue: us-gaap:Revenues
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [110](/filings/0001395942-23-000084.md) | [93.5](/filings/0001395942-25-000007.md) | [105](/filings/0001395942-24-000026.md) | [60.9](/filings/0001395942-24-000059.md) | [132](/filings/0001395942-24-000073.md) | [143](/filings/0001395942-26-000006.md) | [221](/filings/0001395942-25-000027.md) | [119](/filings/0001395942-25-000051.md) | [119](/filings/0001395942-25-000068.md) | [142](/filings/0001395942-26-000031.md) | [180](/filings/0001395942-26-000019.md) | [190](/filings/0001395942-26-000031.md) |
| Current assets | $m | [2,941](/filings/0001395942-23-000084.md) | [2,842](/filings/0001395942-25-000007.md) | [2,958](/filings/0001395942-24-000026.md) | [2,774](/filings/0001395942-24-000059.md) | [2,785](/filings/0001395942-24-000073.md) | [2,852](/filings/0001395942-26-000006.md) | [3,046](/filings/0001395942-25-000027.md) | [2,905](/filings/0001395942-25-000051.md) | [3,106](/filings/0001395942-25-000068.md) | [3,012](/filings/0001395942-26-000031.md) | [3,205](/filings/0001395942-26-000019.md) | [3,329](/filings/0001395942-26-000031.md) |
| Total assets | $m | [4,729](/filings/0001395942-24-000073.md) | [4,726](/filings/0001395942-26-000006.md) | [4,818](/filings/0001395942-25-000027.md) | [4,618](/filings/0001395942-25-000051.md) | [4,626](/filings/0001395942-25-000068.md) | [4,622](/filings/0001395942-26-000006.md) | [4,806](/filings/0001395942-26-000019.md) | [4,638](/filings/0001395942-26-000031.md) | [4,817](/filings/0001395942-25-000068.md) | [4,724](/filings/0001395942-26-000031.md) | [4,900](/filings/0001395942-26-000019.md) | [5,006](/filings/0001395942-26-000031.md) |
| Current liabilities | $m | [2,509](/filings/0001395942-23-000084.md) | [2,479](/filings/0001395942-25-000007.md) | [2,574](/filings/0001395942-24-000026.md) | [2,576](/filings/0001395942-24-000059.md) | [2,585](/filings/0001395942-24-000073.md) | [2,566](/filings/0001395942-26-000006.md) | [2,721](/filings/0001395942-25-000027.md) | [2,509](/filings/0001395942-25-000051.md) | [2,678](/filings/0001395942-25-000068.md) | [2,604](/filings/0001395942-26-000031.md) | [2,767](/filings/0001395942-26-000019.md) | [2,850](/filings/0001395942-26-000031.md) |
| Long-term debt | $m | [201](/filings/0001395942-23-000084.md) | [202](/filings/0001395942-25-000007.md) | [201](/filings/0001395942-24-000026.md) | [0.0](/filings/0001395942-24-000059.md) | [0.0](/filings/0001395942-24-000073.md) | [0.0](/filings/0001395942-26-000006.md) | [0.0](/filings/0001395942-25-000027.md) | [0.0](/filings/0001395942-25-000051.md) | [0.0](/filings/0001395942-25-000068.md) | [530](/filings/0001395942-26-000031.md) | [530](/filings/0001395942-26-000019.md) | [529](/filings/0001395942-26-000031.md) |
| Current portion of debt | $m | [42.3](/filings/0001395942-23-000084.md) | [155](/filings/0001395942-25-000007.md) | [120](/filings/0001395942-24-000026.md) | [272](/filings/0001395942-24-000059.md) | [268](/filings/0001395942-24-000073.md) | [223](/filings/0001395942-26-000006.md) | [226](/filings/0001395942-25-000027.md) | [0.0](/filings/0001395942-25-000051.md) | [15.8](/filings/0001395942-25-000068.md) | [5.5](/filings/0001395942-26-000031.md) | [24.9](/filings/0001395942-26-000019.md) | [5.5](/filings/0001395942-26-000031.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001395942-26-000031.md) | not reported | [0.0](/filings/0001395942-26-000031.md) |
| Shareholders' equity | $m | [1,306](/filings/0001395942-24-000073.md) | [1,327](/filings/0001395942-26-000006.md) | [1,330](/filings/0001395942-25-000051.md) | [1,328](/filings/0001395942-25-000068.md) | [1,327](/filings/0001395942-25-000068.md) | [1,343](/filings/0001395942-26-000031.md) | [1,372](/filings/0001395942-26-000031.md) | [1,416](/filings/0001395942-26-000031.md) | [1,427](/filings/0001395942-25-000068.md) | [1,241](/filings/0001395942-26-000031.md) | [1,254](/filings/0001395942-26-000031.md) | [1,571](/filings/0001395942-26-000031.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [73.6 d](/filings/0001395942-24-000073.md) | [20.8 d](/filings/0001395942-26-000006.md) | [100](/filings/0001395942-25-000027.md) | [37.5 d](/filings/0001395942-25-000051.md) | [122 d](/filings/0001395942-25-000068.md) | [32.7 d](/filings/0001395942-26-000006.md) | [123](/filings/0001395942-26-000019.md) | [71.6 d](/filings/0001395942-26-000031.md) | [72.2 d](/filings/0001395942-25-000068.md) | [126 d](/filings/0001395942-26-000006.md) | [160](/filings/0001395942-26-000019.md) | [52.8 d](/filings/0001395942-26-000031.md) |
| Capital expenditure | $m | [12.9 d](/filings/0001395942-24-000073.md) | [12.2 d](/filings/0001395942-26-000006.md) | [12.9](/filings/0001395942-25-000027.md) | [13.0 d](/filings/0001395942-25-000051.md) | [13.1 d](/filings/0001395942-25-000068.md) | [14.0 d](/filings/0001395942-26-000006.md) | [11.9](/filings/0001395942-26-000019.md) | [14.2 d](/filings/0001395942-26-000031.md) | [14.6 d](/filings/0001395942-25-000068.md) | [14.7 d](/filings/0001395942-26-000006.md) | [13.1](/filings/0001395942-26-000019.md) | [13.8 d](/filings/0001395942-26-000031.md) |
| Share repurchases | $m | [22.2 d](/filings/0001395942-24-000073.md) | [0.0 d](/filings/0001395942-26-000006.md) | [0.0](/filings/0001395942-25-000027.md) | [0.0 d](/filings/0001395942-25-000051.md) | [30.0 d](/filings/0001395942-25-000068.md) | [0.0 d](/filings/0001395942-26-000006.md) | [0.1](/filings/0001395942-26-000019.md) | [9.3 d](/filings/0001395942-26-000031.md) | [26.4 d](/filings/0001395942-25-000068.md) | [9.8 d](/filings/0001395942-26-000006.md) | [25.7](/filings/0001395942-26-000019.md) | [22.5 d](/filings/0001395942-26-000031.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations, us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [115](/filings/0001395942-23-000084.md) | [110](/filings/0001395942-24-000026.md) | [110](/filings/0001395942-24-000059.md) | [110](/filings/0001395942-24-000073.md) | [109](/filings/0001395942-25-000027.md) | [109](/filings/0001395942-25-000051.md) | [109](/filings/0001395942-25-000068.md) | [109](/filings/0001395942-26-000019.md) | [109](/filings/0001395942-26-000031.md) | [108](/filings/0001395942-25-000068.md) | [108](/filings/0001395942-26-000019.md) | [117](/filings/0001395942-26-000031.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 122,797,455 at 2026-07-31, from the cover of the [10-Q filed 2026-08-04](/filings/0001395942-26-000031.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. No prices; not investment advice.